# C_2022120EN.01002601.xml

| 15.3.2022 | EN | Official Journal of the European Union | C 120/26 |
| --- | --- | --- | --- |

15.3.2022

EN

Official Journal of the European Union

C 120/26

---

Prior notification of a concentration

(Case M.10644 – TOWERBROOK CAPITAL PARTNERS / NEW MOUNTAIN CAPITAL / CLOUDMED SOLUTIONS / R1 RCM)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 120/06)

1.

This notification concerns the following undertakings:

| — | TowerBrook Capital Partners L.P. (‘TCP’, United States), |
| --- | --- |

—

TowerBrook Capital Partners L.P. (‘TCP’, United States),

| — | New Mountain Capital, LLC (‘NMC’, United States), |
| --- | --- |

—

New Mountain Capital, LLC (‘NMC’, United States),

| — | R1 RCM, Inc. (‘R1’, United States), currently ultimately controlled by TCP, |
| --- | --- |

—

R1 RCM, Inc. (‘R1’, United States), currently ultimately controlled by TCP,

| — | Cloudmed Solutions LLC (‘Cloudmed’, United States), currently controlled by NMC. |
| --- | --- |

—

Cloudmed Solutions LLC (‘Cloudmed’, United States), currently controlled by NMC.

TCP and NMC will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of R1 and Cloudmed.

The concentration is accomplished by way of purchase of shares.

2.

| — | for TCP: providing investment opportunities to clients in large and middle market European and North American companies across a variety of sectors, including healthcare products and services, retail, luxury, financial services consumer goods, telecommunications, media, chemicals, knowledge services and selected industrial segments, |
| --- | --- |

—

for TCP: providing investment opportunities to clients in large and middle market European and North American companies across a variety of sectors, including healthcare products and services, retail, luxury, financial services consumer goods, telecommunications, media, chemicals, knowledge services and selected industrial segments,

| — | for NMC: managing private equity, credit and net lease capital globally across a variety of industries including healthcare, software, business services, information and data, logistics, financial services and environmental services, |
| --- | --- |

—

for NMC: managing private equity, credit and net lease capital globally across a variety of industries including healthcare, software, business services, information and data, logistics, financial services and environmental services,

| — | for R1: providing technology-driven solutions to improve the patient experience and financial performance of hospitals, health systems and medical groups in North America, |
| --- | --- |

—

for R1: providing technology-driven solutions to improve the patient experience and financial performance of hospitals, health systems and medical groups in North America,

| — | for Cloudmed: providing revenue intelligence solutions for healthcare providers in North America. |
| --- | --- |

—

for Cloudmed: providing revenue intelligence solutions for healthcare providers in North America.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

Case M.10644 – TOWERBROOK CAPITAL PARTNERS / NEW MOUNTAIN CAPITAL / CLOUDMED SOLUTIONS / R1 RCM

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---